?

Les Laboratoires Servier SAS - Strategic SWOT Analysis Review

Date: April 29, 2015
Pages: 42
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: L4F111FA181EN
Leaflet:

Download PDF Leaflet

Les Laboratoires Servier SAS - Strategic SWOT Analysis Review
Les Laboratoires Servier SAS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

SCOPE
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – GlobalData’s summarization of the company’s business strategy.
  • SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief Summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
HIGHLIGHTS

Les Laboratoires Servier SAS (Servier) is an independent French research-based pharmaceutical company. It carries out research and development, manufacture and marketing of drugs for the treatment of cardiovascular diseases, Central nervous system (CNS) diseases, diabetes, cancer and bone, muscle and joint diseases. The company's portfolio of marketed products covers various categories including cardiovascular disease, rheumatology, ENT, venous disease, neurosciences, asthenia, cancer and endocrine disorders. The company invests substantial amount of revenue in R&D. Servier operates research centers in France and Hungary; and International Centers for Therapeutic Research (ICTRs) across the world. With strong presence in international markets, the company sells its products across the world. Servier is headquartered in Suresnes, France.

Les Laboratoires Servier SAS Key Recent Developments

Jul 23, 2013: Galapagos delivers novel osteoarthritis molecules in alliance with Servier
May 23, 2013: miRagen Therapeutics Achieves First Milestone In Strategic Alliance With Servier
Mar 06, 2013: Galapagos Receives €7.5m In Servier Alliances
Jan 07, 2013: Vernalis And Servier Achieve Research Milestone In Third Oncology Collaboration

REASONS TO BUY
  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.
SECTION 1 - ABOUT THE COMPANY

Les Laboratoires Servier SAS - Key Facts
Les Laboratoires Servier SAS - Key Employees
Les Laboratoires Servier SAS - Major Products and Services
Les Laboratoires Servier SAS - Pharmaceutical Pipeline Products Data
Les Laboratoires Servier SAS, Pipeline Products by Therapy Area
Les Laboratoires Servier SAS, Pipeline Products by Development Phase
Les Laboratoires Servier SAS - History
Les Laboratoires Servier SAS - Company Statement
Les Laboratoires Servier SAS - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Les Laboratoires Servier SAS - Business Description
Les Laboratoires Servier SAS - Corporate Strategy
Les Laboratoires Servier SAS - SWOT Analysis
SWOT Analysis - Overview
Les Laboratoires Servier SAS - Strengths
Strength - Strong In-house Research Capabilities
Strength - Market Leadership
Strength - Product Portfolio
Les Laboratoires Servier SAS - Weaknesses
Weakness - Antitrust Investigation
Weakness - Litigations Related to Mediator
Les Laboratoires Servier SAS - Opportunities
Opportunity - Product Pipeline
Opportunity - Agreements and Collaborations
Opportunity - Growing Aged Population in France
Les Laboratoires Servier SAS - Threats
Threat - Increasing Competitive Pressures
Threat - Stringent Government Regulations
Threat - Uncertain R&D Outcomes
Les Laboratoires Servier SAS - Key Competitors

SECTION 3 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Les Laboratoires Servier SAS, Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
Les Laboratoires Servier SAS, Pharmaceuticals & Healthcare, Deals By Type, 2009 to YTD 2015
Les Laboratoires Servier SAS, Recent Deals Summary

SECTION 4 – COMPANY’S RECENT DEVELOPMENTS

Oct 10, 2014: Servier Canada is opening its new Clinical Development Centre in Montreal, and announces a $750 000$ fund at UdeM
Oct 02, 2014: New research partnership with Servier to target Achilles’ heel of many cancers
Aug 04, 2014: Vernalis and Servier achieve two Research Milestones in their Oncology Collaborations
Jul 07, 2014: BioInvent has received milestones from Bayer and Servier
Jul 03, 2014: Servier launches Cardiological, a mobile medical application to understand cardiovascular diseases
Jun 19, 2014: Vernalis and Servier achieve Research Milestone as BCL-2 inhibitor drug candidate enters Phase I
May 23, 2014: The CNRS, the Universities of Montpellier 1 and 2, and SERVIER launch a research collaboration on ischaemic myocardial protection
Apr 16, 2014: Servier Research Group announces the death of President-Founder Dr. Jacques Servier
Mar 25, 2014: Servier inaugurates its subsidiary in Colombia
Mar 07, 2014: Galapagos receives €2 million from osteoarthritis alliance with Servier

SECTION 5 – APPENDIX

Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Les Laboratoires Servier SAS, Key Facts
Les Laboratoires Servier SAS, Key Employees
Les Laboratoires Servier SAS, Major Products and Services
Les Laboratoires Servier SAS, Number of Pipeline Products by Therapy Area
Les Laboratoires Servier SAS, Number of Pipeline Products by Development Stage
Les Laboratoires Servier SAS, Pipeline Products By Therapy Area and Development Phase
Les Laboratoires Servier SAS, History
Les Laboratoires Servier SAS, Other Locations
Les Laboratoires Servier SAS, Subsidiaries
Les Laboratoires Servier SAS, Key Competitors
Les Laboratoires Servier SAS, Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
Les Laboratoires Servier SAS, Pharmaceuticals & Healthcare, Deals By Type, 2009 to YTD 2015
Les Laboratoires Servier SAS, Recent Deals Summary

LIST OF FIGURES

Les Laboratoires Servier SAS, Pipeline Products by Therapy Area
Les Laboratoires Servier SAS, Pipeline Products by Development Phase
Les Laboratoires Servier SAS, Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
Les Laboratoires Servier SAS, Pharmaceuticals & Healthcare, Deals by Type, 2009 to YTD 2015
Skip to top


Ask Your Question

Les Laboratoires Servier SAS - Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: